A total of 153 institutions have reported a stake in Nektar Therapeutics (NASDAQ:NKTR) as of September 2025, according to recent 13F filings with the SEC.
| Owner Name | Date | Shares Held | Change (QoQ) | Change (%) | Value (USD) |
|---|---|---|---|---|---|
| BVF INC/IL | 30 Sep, 2025 | 1,276,595 | 1,276,595 | 0.00% | $72,638,256.00 |
| VANGUARD GROUP INC | 30 Sep, 2025 | 948,647 | 219,155 | 30.04% | $53,978,015.00 |
| MORGAN STANLEY | 30 Sep, 2025 | 929,151 | 857,012 | 1,188.00% | $52,868,691.00 |
| SUSQUEHANNA INTERNATIONAL GROUP, LLP | 30 Sep, 2025 | 924,896 | 703,005 | 316.82% | $52,626,582.00 |
| FARALLON CAPITAL MANAGEMENT LLC | 30 Sep, 2025 | 791,000 | 791,000 | 0.00% | $45,007,900.00 |
| BlackRock, Inc. | 30 Sep, 2025 | 609,114 | 193,888 | 46.69% | $34,658,587.00 |
| MILLENNIUM MANAGEMENT LLC | 30 Sep, 2025 | 570,994 | -157,039 | -21.57% | $32,489,559.00 |
| TWO SIGMA INVESTMENTS, LP | 30 Sep, 2025 | 434,237 | 354,842 | 446.93% | $24,708,085.00 |
| Nantahala Capital Management, LLC | 30 Sep, 2025 | 418,522 | -291,239 | -41.03% | $23,813,902.00 |
| CITADEL ADVISORS LLC | 30 Sep, 2025 | 361,073 | 361,073 | 0.00% | $20,545,053.00 |
| 22NW, LP | 30 Sep, 2025 | 331,115 | 185,000 | 126.61% | $18,840,443.00 |
| EMERALD ADVISERS, LLC | 30 Sep, 2025 | 323,246 | 323,246 | 0.00% | $18,392,697.00 |
| Jefferies Financial Group Inc. | 30 Sep, 2025 | 303,200 | 303,200 | 0.00% | $17,252,080.00 |
| GREAT POINT PARTNERS LLC | 30 Sep, 2025 | 300,000 | 300,000 | 0.00% | $17,070,000.00 |
| PRIMECAP MANAGEMENT CO/CA/ | 30 Sep, 2025 | 289,050 | -10,668 | -3.56% | $16,446,945.00 |
| RENAISSANCE TECHNOLOGIES LLC | 30 Sep, 2025 | 278,541 | 31,481 | 12.74% | $15,848,983.00 |
| ARMISTICE CAPITAL, LLC | 30 Sep, 2025 | 268,000 | 144,000 | 116.13% | $15,249,200.00 |
| EMERALD MUTUAL FUND ADVISERS TRUST | 30 Sep, 2025 | 233,205 | 233,205 | 0.00% | $13,269,365.00 |
| Woodline Partners LP | 30 Sep, 2025 | 233,059 | -13,086 | -5.32% | $13,261,057.00 |
| Invesco Ltd. | 30 Sep, 2025 | 226,897 | 194,865 | 608.34% | $12,910,443.00 |